UDI: Value Beyond Compliance
In this AHRMM webcast, Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the value of UDI adoption in health care organizations.
AHRMM’s Mike Schiller, senior director of supply chain, joins the conversation by describing the actions AHRMM is taking with the Learning UDI Community (LUC) to identify adoption practices and move beyond compliance.
Related Resources
Advisory
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ
Toolkits/Methodology
How-to guide to managing IV disruptions.
Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years.
The AHRMM Cost, Quality, and Outcomes (CQO) Movement frames the critical role supply chain professionals play in driving high quality care, at a more…